Givaudan | GIVN - Bruttoergebnis Vom Umsatz

Aktienkurs
2,880.00
Täglich Wechseln
-20.00 -0.69%
Monatlich
-5.85%
Jährlich
-29.08%
Q1 Prognose
2,807.71




Bruttoergebnis Vom Umsatz Veränderung Datum
Air Liquide EUR 8.65B 4.44B 2024-12
Akzo Nobel EUR 1.04B 10M 2025-06
Anheuser-Busch USD 8.54B 91M 2025-09
Arkema EUR 455M 14M 2025-06
Associated British Foods GBP 382.5M 8.73B 2024-12
BASF EUR 3.11B 55M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Beiersdorf EUR 1.54B 1.16B 2025-06
British American Tobacco GBP 5.09B 6.36B 2024-06
Covestro EUR 488M 64M 2025-09
Croda International GBP 366.7M 183.1M 2024-12
Danone EUR 6.82B 23M 2024-12
Diageo GBP 6.39B 950M 2025-12
Fresenius EUR 1.51B 214M 2025-12
Fresenius Medical Care EUR 1.39B 147M 2025-12
Givaudan CHF 823M 575M 2024-06
Heineken EUR 3.16B 276M 2024-12
International Flavors Fragrances USD 890M 93M 2025-12
Johnson Matthey GBP 480M 33M 2024-06
Kerry EUR 4.71B 656.3M 2022-12
Lonza CHF 1.29B 248M 2025-06
L'Oréal EUR 15.96B 822.8M 2025-12
Merck EUR 3.21B 186M 2025-09
Nestle CHF 21.43B 174M 2024-12
Pernod Ricard EUR 3.11B 371M 2025-12
Reckitt Benckiser GBP 4.25B 2.08B 2024-12
SGS CHF 762.5M 48.5M 2024-12
Sika AG CHF 3.13B 69.3M 2025-06
Solvay EUR 265M 13M 2025-09
Tate & Lyle GBP 902M 53M 2023-06
Umicore EUR 308.6M 10.45M 2024-12
Victrex GBP 68.3M 4M 2025-12